Tags: Drug.

Octreotide (brand name Sandostatin Novartis Pharmaceuticals) is an octapeptide that mimics natural somatostatin pharmacologically though it is a more potent inhibitor of growth hormone glucagon and insulin than the natural hormone. It was first synthesized in 1979 by the chemist Wilfried Bauer.

Octreotide.svg
ATC prefix
H01
ATC suffix
CB02
Bioavailability
60.0
CAS number
83150-76-9
CAS supplemental
(acetate), (pamoate)
DrugBank
DB00104
FDA UNII code
RWM8CCW8GP
IUPAC name
(2R)-2-amino-3-phenyl-propanoyl]amino]-16-benzyl-N-[(2R3R)-13-dihydroxybutan-2-yl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-69121518-pentaoxo-12-dithia-58111417-pentazacycloicosane-4-carboxamide, (4R7S10S13R16S19R)-10-(4-aminobutyl)-19-
PubChem
383414

Loading...

This page contains content from the copyrighted Wikipedia article "Octreotide"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.